TCT-114 Abstract Withdrawn  by unknown
www.jacctctabstracts2014.com SATURDAY, SEPTEMBER 13, 2014, 5:00 PM–7:00 PMTCT-114
Abstract Withdrawn
TCT-115
Hybrid Approach of Percutaneous Coronary Intervention Followed by
Minimally Invasive Single Valve Surgery: Outcomes by STS Risk Stratiﬁcation
Andres M. Pineda1, Juan P. Rodriguez-Escudero1, Christos G. Mihos1,
Orlando Santana2, Joseph Lamelas1, Nirat Beohar3
1Mount Sinai Heart Institute, Miami Beach, FL, 2Columbia University Division of
Cardiology, at the Mount Sinai Heart Institute, Miami Beach, FL, 3Columbia
University Division of Cardiology at Mt. Sinai Medical Center, Miami Beach,
United States
Background: A hybrid approach of PCI followed by minimally invasive valve sur-
gery (MIVS), rather than combined median sternotomy CABG and valve surgery,
may be preferred for high risk patients with coronary and valvular disease. We
therefore evaluated the outcomes of such patients stratiﬁed based on their predicted
STS mortality risk score.
Methods:We retrospectively evaluated all consecutive patients with concomitant
coronary artery and valvular heart disease who underwent a hybrid procedure
for isolated valve surgery at our institution between February 2009 and July
2013.
Results: A total of 185 patients were stratiﬁed based on their STS score in to
low- (STS < 3%, mean 1.9), intermediate- (STS 3-8%, mean 4.7), and high-risk
(STS > 8%, mean 13.1). High-risk patients were older, more were female, and
had worse baseline characteristics, including preoperative renal function and
ejection fraction (Table). There was no difference in the PCI characteristics
between the groups, and most patients had single vessel PCI (81%) and a drug-
eluting stent placed (71%). Within a median of 41 days after the PCI, patients
underwent ﬁrst time (85%) or redo (15%) MIVS, and 68% were on dual anti-
platelet therapy. Post-operatively, high risk patients required more blood trans-
fusions, had an increased incidence of acute kidney injury, and longer intensive
care unit and hospital lengths of stay. The overall 30-day mortality was 4%. The
30-day mortality for the intermediate- and high-risk groups was lower than the
predicted STS mortality (3 vs. 4.7% and 11 vs. 13.1%, respectively). Long-term
follow-up (mean 15.4 months) was available for 96% of the patients, with an













Age (years, mean  SD) 748 718 787 7710 <0.001
Ejection fraction (%, median,
IQR)
55(45-63) 58(53-65) 55(41-60) 44(31-59) 0.002
Preoperative creatinine (mg/
dl, median, IQR)
1.0(0.8-1.2) 1.0(0.8-1.1) 1.0(0.9-1.2) 2(1.1-3.6) <0.001
Predicted STS mortality risk
score (%, mean  SD)
4.23.6 1.90.6 4.71.3 13.15 <0.001
Drug eluting stent (%) 130(71) 65(73) 57(73) 8(50) 0.23
Single-vessel PCI (%) 149(81) 76(85) 58(74) 15(83) 0.51
Time of PCI to valve surgery
(days, median, IQR)
41(19-67) 38(19-65) 45(26-76) 33(6-54) 0.39
Preoperative dual
antiplatelet therapy (%)
137(68) 56(63) 58(74) 13(72) 0.27
Total ICU length of stay
(hours, median, IQR)
46(27-74) 45(24-73) 45(29-73) 68(40-156) 0.001
Total hospital length of stay
(days, median, IQR)
6(7-10) 7(5-9) 8(6-10) 9(8-11) 0.03
Postoperative PRBC (units,
mean  SD)
1.11.9 0.71.3 1.11.4 2.54.6 0.002
30-Day mortality 7(4) 2(2) 3(3) 2(11) 0.19
MACCE at follow-up (%) 44(25) 16(18) 19(26) 9(53) 0.01
All-cause of mortality at
follow-up (%)
24(13) 7(7) 11(14) 6(33) 0.01
Abbreviations: PCI¼percutaneous coronary intervention, SD¼standard deviation,
IQR¼interquartile range, STS¼Society of Thoracic Surgeons, ICU¼ intensive care unit,
PRBC¼pack of red blood cells, MACCE¼major adverse cardiovascular and cerebrovascular
events.Conclusions: A hybrid approach of PCI followed by MIVS for isolated valve
surgery can be performed with excellent results in intermediate and high risk
patients.JACC Vol 64/11/Suppl B j September 13–17, 2014 j TCT Abstracts/AngioplasTCT-116
Periprocedural Checklist In Catheterization Laboratory Is Associated With
Reduced Rate Of Treatment Complications
Michal Hawranek1, Pawel Gasior1, Piotr Buchta1, Marek Gierlotka1,
Krystyna Czapla1, Andrzej Lekston1, Lech Polonski1, Mariusz Gasior1
1Medical University of Silesia, Silesian Center for Heart Diseases, Zabrze, Poland
Background: Interventional cardiology is a discipline with growing number of
complex procedures, which are exposed to occurrence of many complications. The
aim of the study was to assess efﬁcacy and legitimacy of periprocedural checklist in
prevention of cardiovascular adverse events, in elective patients undergoing invasive
diagnostic and treatment.
Methods: 2064 patients directed to treatment in catheterization laboratory between V
2011 to VIII 2012 were analyzed. Patients who were hospitalized without invasive
diagnostic and treatment were not included into the study. Patients were divided into
two groups: control group- 1011 patients with invasive diagnostics and treatment
before introduction of periprocedural checklist; intervention group- 1053 patients with
invasive diagnostics and treatment after introduction of periprocedural checklist. We
analyzed studied groups assessing adverse events associated with hospitalization and
performed procedures. We also conducted subjective evaluation of checklist by
medical staff on the basis of a questionnaire.
Results: Baseline characteristic between studied groups was comparable, except
higher rate of stable coronary artery disease (50.7 vs 39.6% p¼< 0.001) and and
electrophysiology procedures in control group. Implementation of checklist was
favorable in case of decreased adverse events (6.8 vs. 3.9% p¼0.004) especially
bleedings (2.3 vs 0,3% p< 0.001). Multivariate analysis conﬁrmed that lack of per-
iprocedural checklist during hospitalization was an independent factor associated with
higher rate of adverse events (OR¼2.97, 95 CI¼1.60 – 5.53, p¼0.001). Subjective
evaluation of medical staff opinion showed that implementation of checklist seems to
be associated with improved communication skills, work organization, prevented
occurrence of medical errors and reduced rate of complications associated with
procedures
Conclusions: Introduction of periprocedural checklist was associated with signiﬁcant
reduction of adverse events among patients undergoing invasive procedures. It has
also positive inﬂuence on team communication, organization and quality of treatment,
according to medical staff opinion.
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Impact of a Paleolithic Diet on Modiﬁable Cardiovascular Risk Factors
Deepak Talreja1
1Eastern Virginia Medical School/ Sentara, Virginia Beach, VA
Background: The paleolithic diet is a nutritional plan consisting primarily of grass-
fed pasture-raised meats, seafood, vegetables, and secondarily fruits, seeds, eggs, and
nuts which mimics the diet consumed by our pre-agricultural, hunter-gatherer an-
cestors. The diet has been shown to promote weight loss. Compared to other popular
diets, the paleolithic diet is relatively balanced in its protein, carbohydrate and fat
content. Reﬁned sugars, starches, dairy, and legumes are avoided.
Methods: Nondiabetic adults between ages 35 and 85 with one or more risk factors
for cardiovascular disease (CVD) were invited to participate in a comprehensive
nutrition program and a 60-day diet intervention. An initial health screen was per-
formed to assess weight, blood pressure, fasting glucose, hemoglobin A1c, highly
sensitive C-reactive protein, lipids and NMR LipoProﬁle. Participants maintained a
daily food log and meet once weekly with the multi-disciplinary study team to review
food logs. At the end of the 60-day intervention and at 6 months, the health screen was
repeated and dietary intake logs were evaluated. This group is part of a much larger
study (the Va Beach Diet Study with 4 parallel groups – Mediterranean, DASH, Paleo
and Dash Diets). We plan to submit the whole as a late breaking trial the entire study
to TCT including genetic screening and predictors of diabetes.
Results: After 60 days on a paleolithic diet, patients lost on averge 12 lbs (6.7%).
There were no changes in LDL-P/LDL-C levels however, VLDL-P and TG levels
were signiﬁcantly reduced. HDL-P was signiﬁcantly decreased. Blood pressure (both
SBP an DBP) signiﬁcantly improved with the diet over 10 MmHg. Fasting glucose
and HbA1c were not signiﬁcantly changed. See chart
Conclusions: Consumption of a paleolithic diet in adults with cardiovascular risk
factors promoted weight loss, improved blood pressure and reduced triglycerides and
lipoprotein markers associated with insulin resistance. Three other diets were also
evaluated in this study: a Mediterranean, DASH diet and Vegan diet. Compared to
these three diets, the paleolithic diet produced the greatest triglyceride loweringty Overview and Outcomes B35
